APO Research
Talk to an analyst

APO RESEARCH · REPORT

Percutaneous Transluminal Angioplasty Instrument

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Percutaneous Transluminal Angioplasty Instrument Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

8 January 2026195 pages

Choose your research edition.

Industry ResearchPercutaneous Transluminal Angioplasty Instrument Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Percutaneous Transluminal Angioplasty Instrument Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Percutaneous Transluminal Angioplasty Instrument Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Percutaneous Transluminal Angioplasty Instrument Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Percutaneous Transluminal Angioplasty Instrument Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Percutaneous Transluminal Angioplasty Instrument market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Percutaneous Transluminal Angioplasty Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Percutaneous Transluminal Angioplasty Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Percutaneous Transluminal Angioplasty Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Percutaneous Transluminal Angioplasty Instrument is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Percutaneous Transluminal Angioplasty Instrument include Abbott, Boston Scientific, Medtronic, Terumo Medical, Lepu Medical, MicroPort, Biosensors, B.Braun and Atrium Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Percutaneous Transluminal Angioplasty Instrument market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Percutaneous Transluminal Angioplasty Instrument and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Percutaneous Transluminal Angioplasty Instrument revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Percutaneous Transluminal Angioplasty Instrument market size, projected growth trends, production technologies, key applications, and end-use industries.

Percutaneous Transluminal Angioplasty Instrument Segment by Company

Abbott

Boston Scientific

Medtronic

Terumo Medical

Lepu Medical

MicroPort

Biosensors

B.Braun

Atrium Medical

Biotronik

Asahi Intecc

Cardinal

Integer

Cook Medical

TE Connectivity

Merit

SP Medical

Percutaneous Transluminal Angioplasty Instrument Segment by Type

Introducer

Angiographic Catheter

Balloon Catheter

Guide Wire

Stent

Others

Percutaneous Transluminal Angioplasty Instrument Segment by Application

Below 40 Years Old

40 ~ 60 Years Old

Above 60 Years Old

Percutaneous Transluminal Angioplasty Instrument Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Percutaneous Transluminal Angioplasty Instrument market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Percutaneous Transluminal Angioplasty Instrument and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Percutaneous Transluminal Angioplasty Instrument.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Percutaneous Transluminal Angioplasty Instrument in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Percutaneous Transluminal Angioplasty Instrument industry.

Chapter 3: Detailed analysis of Percutaneous Transluminal Angioplasty Instrument companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Percutaneous Transluminal Angioplasty Instrumentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Introducer Table 3. Key Players of Angiographic Catheter Table 4. Key Players of Balloon Catheter Table 3. Key Players of Guide Wire Table 4. Key Players of Stent Table 5. Key Players of Others Table 6. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Below 40 Years Old Table 8. Key Players of 40 ~ 60 Years Old Table 9. Key Players of Above 60 Years Old Table 10. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Region (2021-2026) Table 13. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Region (2027-2032) Table 15. Percutaneous Transluminal Angioplasty Instrument Industry Trends Table 16. Percutaneous Transluminal Angioplasty Instrument Industry Drivers Table 17. Percutaneous Transluminal Angioplasty Instrument Industry Opportunities and Challenges Table 18. Percutaneous Transluminal Angioplasty Instrument Industry Restraints Table 19. Global Percutaneous Transluminal Angioplasty Instrument Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Company (2021-2026) Table 21. Global Percutaneous Transluminal Angioplasty Instrument Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Percutaneous Transluminal Angioplasty Instrument Key Company Head Office and Area Served Table 23. Global Percutaneous Transluminal Angioplasty Instrument Company, Product Type & Application Table 24. Global Percutaneous Transluminal Angioplasty Instrument Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Percutaneous Transluminal Angioplasty Instrument by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Type (2021-2026) Table 31. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Type (2027-2032) Table 32. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Application (2021-2026) Table 36. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Application (2027-2032) Table 37. Abbott Company Information Table 38. Abbott Business Overview Table 39. Abbott Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Abbott Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 41. Abbott Recent Development Table 42. Boston Scientific Company Information Table 43. Boston Scientific Business Overview Table 44. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 46. Boston Scientific Recent Development Table 47. Medtronic Company Information Table 48. Medtronic Business Overview Table 49. Medtronic Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Medtronic Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 51. Medtronic Recent Development Table 52. Terumo Medical Company Information Table 53. Terumo Medical Business Overview Table 54. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 56. Terumo Medical Recent Development Table 57. Lepu Medical Company Information Table 58. Lepu Medical Business Overview Table 59. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 61. Lepu Medical Recent Development Table 62. MicroPort Company Information Table 63. MicroPort Business Overview Table 64. MicroPort Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. MicroPort Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 66. MicroPort Recent Development Table 67. Biosensors Company Information Table 68. Biosensors Business Overview Table 69. Biosensors Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Biosensors Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 71. Biosensors Recent Development Table 72. B.Braun Company Information Table 73. B.Braun Business Overview Table 74. B.Braun Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. B.Braun Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 76. B.Braun Recent Development Table 77. Atrium Medical Company Information Table 78. Atrium Medical Business Overview Table 79. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 81. Atrium Medical Recent Development Table 82. Biotronik Company Information Table 83. Biotronik Business Overview Table 84. Biotronik Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Biotronik Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 86. Biotronik Recent Development Table 87. Asahi Intecc Company Information Table 88. Asahi Intecc Business Overview Table 89. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 91. Asahi Intecc Recent Development Table 92. Cardinal Company Information Table 93. Cardinal Business Overview Table 94. Cardinal Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Cardinal Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 96. Cardinal Recent Development Table 97. Integer Company Information Table 98. Integer Business Overview Table 99. Integer Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Integer Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 101. Integer Recent Development Table 102. Cook Medical Company Information Table 103. Cook Medical Business Overview Table 104. Cook Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 106. Cook Medical Recent Development Table 107. TE Connectivity Company Information Table 108. TE Connectivity Business Overview Table 109. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 111. TE Connectivity Recent Development Table 112. Merit Company Information Table 113. Merit Business Overview Table 114. Merit Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. Merit Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 116. Merit Recent Development Table 117. SP Medical Company Information Table 118. SP Medical Business Overview Table 119. SP Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. SP Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio Table 121. SP Medical Recent Development Table 122. North America Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026) & (US$ Million) Table 123. North America Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032) & (US$ Million) Table 124. North America Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026) & (US$ Million) Table 125. North America Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032) & (US$ Million) Table 126. North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026) Table 128. North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032) Table 129. Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026) & (US$ Million) Table 130. Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032) & (US$ Million) Table 131. Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026) & (US$ Million) Table 132. Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032) & (US$ Million) Table 133. Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026) Table 135. Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032) Table 136. China Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026) & (US$ Million) Table 137. China Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032) & (US$ Million) Table 138. China Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026) & (US$ Million) Table 139. China Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032) & (US$ Million) Table 140. Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026) & (US$ Million) Table 141. Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032) & (US$ Million) Table 142. Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026) & (US$ Million) Table 143. Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032) & (US$ Million) Table 144. Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026) Table 146. Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032) Table 147. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026) & (US$ Million) Table 148. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032) & (US$ Million) Table 149. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026) & (US$ Million) Table 150. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032) & (US$ Million) Table 151. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026) Table 153. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032) Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Percutaneous Transluminal Angioplasty Instrument Product Image Figure 2. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Type: 2025 VS 2032 Figure 4. Introducer Image Figure 5. Angiographic Catheter Image Figure 6. Balloon Catheter Image Figure 7. Guide Wire Image Figure 8. Stent Image Figure 9. Others Image Figure 10. Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Application: 2025 VS 2032 Figure 12. Below 40 Years Old Image Figure 13. 40 ~ 60 Years Old Image Figure 14. Above 60 Years Old Image Figure 15. Global Percutaneous Transluminal Angioplasty Instrument Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 17. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Percutaneous Transluminal Angioplasty Instrument Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Percutaneous Transluminal Angioplasty Instrument Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Type (2021-2032) Figure 24. Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Percutaneous Transluminal Angioplasty Instrument Revenue Market Share by Application (2021-2032) Figure 26. North America Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 27. North America Percutaneous Transluminal Angioplasty Instrument Market Share by Type (2021-2032) Figure 28. North America Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2021-2032) Figure 29. North America Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032) Figure 30. United States Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 31. Canada Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 33. Europe Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 34. Europe Percutaneous Transluminal Angioplasty Instrument Market Share by Type (2021-2032) Figure 35. Europe Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2021-2032) Figure 36. Europe Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032) Figure 37. Germany Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 38. France Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 40. Italy Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 41. Russia Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 43. China Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 44. China Percutaneous Transluminal Angioplasty Instrument Market Share by Type (2021-2032) Figure 45. China Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2021-2032) Figure 46. Asia Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 47. Asia Percutaneous Transluminal Angioplasty Instrument Market Share by Type (2021-2032) Figure 48. Asia Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2021-2032) Figure 49. Asia Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032) Figure 50. Japan Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 54. India Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 55. Australia Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032) Figure 60. Brazil Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 65. UAE Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 67. Chile Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Introducer
  • Angiographic Catheter
  • Balloon Catheter
  • Guide Wire
  • Stent
  • Others
Applications
  • Below 40 Years Old
  • 40 ~ 60 Years Old
  • Above 60 Years Old
Companies covered
  • Abbott
  • Boston Scientific
  • Medtronic
  • Terumo Medical
  • Lepu Medical
  • MicroPort
  • Biosensors
  • B.Braun
  • Atrium Medical
  • Biotronik
  • Asahi Intecc
  • Cardinal
  • Integer
  • Cook Medical
  • TE Connectivity
  • Merit
  • SP Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Introducer
  5. 1.2.3 Angiographic Catheter
  6. 1.2.4 Balloon Catheter
  7. 1.2.5 Guide Wire
  8. 1.2.6 Stent
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Below 40 Years Old
  13. 1.3.3 40 ~ 60 Years Old
  14. 1.3.4 Above 60 Years Old
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Percutaneous Transluminal Angioplasty Instrument Growth Trends by Region
  17. 1.5.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2021-2026)
  19. 1.5.3 Percutaneous Transluminal Angioplasty Instrument Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Percutaneous Transluminal Angioplasty Instrument Market Dynamics
  1. 2.1 Percutaneous Transluminal Angioplasty Instrument Industry Trends
  2. 2.2 Percutaneous Transluminal Angioplasty Instrument Industry Drivers
  3. 2.3 Percutaneous Transluminal Angioplasty Instrument Industry Opportunities and Challenges
  4. 2.4 Percutaneous Transluminal Angioplasty Instrument Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Percutaneous Transluminal Angioplasty Instrument Revenue by Company (2021-2026)
  2. 3.2 Global Percutaneous Transluminal Angioplasty Instrument Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Percutaneous Transluminal Angioplasty Instrument Key Company Head office and Area Served
  4. 3.4 Global Percutaneous Transluminal Angioplasty Instrument Company, Product Type & Application
  5. 3.5 Global Percutaneous Transluminal Angioplasty Instrument Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Percutaneous Transluminal Angioplasty Instrument Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Percutaneous Transluminal Angioplasty Instrument Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Percutaneous Transluminal Angioplasty Instrument Tier 1, Tier 2, and Tier 3
4 Percutaneous Transluminal Angioplasty Instrument Market by Type
  1. 4.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2032)
  3. 4.3 Global Percutaneous Transluminal Angioplasty Instrument Market Size Share by Type (2021-2032)
5 Percutaneous Transluminal Angioplasty Instrument Market by Application
  1. 5.1 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2032)
  3. 5.3 Global Percutaneous Transluminal Angioplasty Instrument Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbott Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Boston Scientific
  8. 6.2.1 Boston Scientific Company Information
  9. 6.2.2 Boston Scientific Business Overview
  10. 6.2.3 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Boston Scientific Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  12. 6.2.5 Boston Scientific Recent Developments
  13. 6.3 Medtronic
  14. 6.3.1 Medtronic Company Information
  15. 6.3.2 Medtronic Business Overview
  16. 6.3.3 Medtronic Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Medtronic Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  18. 6.3.5 Medtronic Recent Developments
  19. 6.4 Terumo Medical
  20. 6.4.1 Terumo Medical Company Information
  21. 6.4.2 Terumo Medical Business Overview
  22. 6.4.3 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Terumo Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  24. 6.4.5 Terumo Medical Recent Developments
  25. 6.5 Lepu Medical
  26. 6.5.1 Lepu Medical Company Information
  27. 6.5.2 Lepu Medical Business Overview
  28. 6.5.3 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Lepu Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  30. 6.5.5 Lepu Medical Recent Developments
  31. 6.6 MicroPort
  32. 6.6.1 MicroPort Company Information
  33. 6.6.2 MicroPort Business Overview
  34. 6.6.3 MicroPort Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 MicroPort Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  36. 6.6.5 MicroPort Recent Developments
  37. 6.7 Biosensors
  38. 6.7.1 Biosensors Company Information
  39. 6.7.2 Biosensors Business Overview
  40. 6.7.3 Biosensors Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Biosensors Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  42. 6.7.5 Biosensors Recent Developments
  43. 6.8 B.Braun
  44. 6.8.1 B.Braun Company Information
  45. 6.8.2 B.Braun Business Overview
  46. 6.8.3 B.Braun Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 B.Braun Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  48. 6.8.5 B.Braun Recent Developments
  49. 6.9 Atrium Medical
  50. 6.9.1 Atrium Medical Company Information
  51. 6.9.2 Atrium Medical Business Overview
  52. 6.9.3 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Atrium Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  54. 6.9.5 Atrium Medical Recent Developments
  55. 6.10 Biotronik
  56. 6.10.1 Biotronik Company Information
  57. 6.10.2 Biotronik Business Overview
  58. 6.10.3 Biotronik Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Biotronik Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  60. 6.10.5 Biotronik Recent Developments
  61. 6.11 Asahi Intecc
  62. 6.11.1 Asahi Intecc Company Information
  63. 6.11.2 Asahi Intecc Business Overview
  64. 6.11.3 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Asahi Intecc Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  66. 6.11.5 Asahi Intecc Recent Developments
  67. 6.12 Cardinal
  68. 6.12.1 Cardinal Company Information
  69. 6.12.2 Cardinal Business Overview
  70. 6.12.3 Cardinal Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Cardinal Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  72. 6.12.5 Cardinal Recent Developments
  73. 6.13 Integer
  74. 6.13.1 Integer Company Information
  75. 6.13.2 Integer Business Overview
  76. 6.13.3 Integer Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Integer Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  78. 6.13.5 Integer Recent Developments
  79. 6.14 Cook Medical
  80. 6.14.1 Cook Medical Company Information
  81. 6.14.2 Cook Medical Business Overview
  82. 6.14.3 Cook Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Cook Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  84. 6.14.5 Cook Medical Recent Developments
  85. 6.15 TE Connectivity
  86. 6.15.1 TE Connectivity Company Information
  87. 6.15.2 TE Connectivity Business Overview
  88. 6.15.3 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 TE Connectivity Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  90. 6.15.5 TE Connectivity Recent Developments
  91. 6.16 Merit
  92. 6.16.1 Merit Company Information
  93. 6.16.2 Merit Business Overview
  94. 6.16.3 Merit Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Merit Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  96. 6.16.5 Merit Recent Developments
  97. 6.17 SP Medical
  98. 6.17.1 SP Medical Company Information
  99. 6.17.2 SP Medical Business Overview
  100. 6.17.3 SP Medical Percutaneous Transluminal Angioplasty Instrument Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 SP Medical Percutaneous Transluminal Angioplasty Instrument Product Portfolio
  102. 6.17.5 SP Medical Recent Developments
7 North America
  1. 7.1 North America Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
  2. 7.2 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Type
  3. 7.2.1 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026)
  4. 7.2.2 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032)
  5. 7.2.3 North America Percutaneous Transluminal Angioplasty Instrument Market Share by Type (2021-2032)
  6. 7.3 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Application
  7. 7.3.1 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026)
  8. 7.3.2 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032)
  9. 7.3.3 North America Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2021-2032)
  10. 7.4 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country
  11. 7.4.1 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
  13. 7.4.3 North America Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032)
  14. 7.4.4 North America Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
  2. 8.2 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Type
  3. 8.2.1 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026)
  4. 8.2.2 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032)
  5. 8.2.3 Europe Percutaneous Transluminal Angioplasty Instrument Market Share by Type (2021-2032)
  6. 8.3 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Application
  7. 8.3.1 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026)
  8. 8.3.2 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032)
  9. 8.3.3 Europe Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2021-2032)
  10. 8.4 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country
  11. 8.4.1 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
  13. 8.4.3 Europe Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032)
  14. 8.4.4 Europe Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
  2. 9.2 China Percutaneous Transluminal Angioplasty Instrument Market Size by Type
  3. 9.2.1 China Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026)
  4. 9.2.2 China Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032)
  5. 9.2.3 China Percutaneous Transluminal Angioplasty Instrument Market Share by Type (2021-2032)
  6. 9.3 China Percutaneous Transluminal Angioplasty Instrument Market Size by Application
  7. 9.3.1 China Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026)
  8. 9.3.2 China Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032)
  9. 9.3.3 China Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
  2. 10.2 Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Type
  3. 10.2.1 Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026)
  4. 10.2.2 Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032)
  5. 10.2.3 Asia Percutaneous Transluminal Angioplasty Instrument Market Share by Type (2021-2032)
  6. 10.3 Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Application
  7. 10.3.1 Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026)
  8. 10.3.2 Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032)
  9. 10.3.3 Asia Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2021-2032)
  10. 10.4 Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Country
  11. 10.4.1 Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
  13. 10.4.3 Asia Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032)
  14. 10.4.4 Asia Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Percutaneous Transluminal Angioplasty Instrument Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst